First Horizon Foundation Gives $5 Million to Launch New UTHSC Medical Building
UT Health Science Center is getting an early boost toward its new College of Medicine building, thanks to a $5 million gift from the First Horizon Foundation.
UTHSC In the Media
WKNO Daily Newscast | Friday, August 14, 2026
The University of Tennessee Health Sciences is getting a jump-start on its new College of Medicine Interdisciplinary Building, thanks to a $5 million donation by the First Horizon Foundation.
NP-Led Telemedicine a Solid Option in Acute Stroke Management
The findings, from a feasibility study, show how specially trained NPs can enhance care in centers short on vascular neurologists.
Q&A: Anaphylaxis Recognition and Epinephrine Use, With Jay Lieberman, MD
Anaphylaxis recognition criteria have not been updated to reflect infant-specific presentations, even as newer international definitions already incorporate them.
Q&A: Anaphylaxis Recognition and Epinephrine Use, With Jay Lieberman, MD
Anaphylaxis recognition criteria have not been updated to reflect infant-specific presentations, even as newer international definitions already incorporate them.
Dunn earns Doctor of Medicine, begins urology residency
Alexis Mikaylin Dunn, granddaughter of the late John and Leanna Koemel of George West and the daughter of Kevin and Kristen Koemel Dunn off Houston, graduated from the University of Mississippi Medical Center on Friday, May 23, 2025.
Stock Epinephrine Could Close Anaphylaxis Care Gap, With Jay Lieberman, MD
Reframing when caregivers reach for epinephrine and expanding stock epinephrine access could meaningfully reduce delayed treatment in infants and toddlers with anaphylaxis, according to Jay Lieberman, MD, professor at the University of Tennessee Health Science Center and program director of the Allergy/Immunology Fellowship Program at Le Bonheur Children’s Hospital.
Stock Epinephrine Could Close Anaphylaxis Care Gap, With Jay Lieberman, MD
Reframing when caregivers reach for epinephrine and expanding stock epinephrine access could meaningfully reduce delayed treatment in infants and toddlers with anaphylaxis, according to Jay Lieberman, MD, professor at the University of Tennessee Health Science Center and program director of the Allergy/Immunology Fellowship Program at Le Bonheur Children’s Hospital.